• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局灶型和特发性多中心 Castleman 病的淋巴结转录组。

The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.

机构信息

Division of Hematopathology, Mayo Clinic, Rochester, MN.

Center for Cytokine Storm Treatment and Laboratory, University of Pennsylvania, Philadelphia, PA.

出版信息

Haematologica. 2023 Jan 1;108(1):207-218. doi: 10.3324/haematol.2021.280370.

DOI:10.3324/haematol.2021.280370
PMID:35484648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9827154/
Abstract

Castleman disease is a polyclonal lymphoproliferative disorder characterized by unicentric or multicentric lymphadenopathy with characteristic histomorphological features, in addition to variable inflammatory symptomatology. The molecular mechanisms and etiologies of unicentric Castleman disease (UCD) and idiopathic multicentric Castleman disease (iMCD) are poorly understood, and identification of targetable disease mediators remains an unmet clinical need. We performed whole exome sequencing on lymph node biopsies from patients with UCD and iMCD and compared the transcriptomic profiles to that of benign control lymph nodes. We identified significantly upregulated genes in UCD (n=443), iMCD (n=316) or both disease subtypes (n=51) and downregulated genes in UCD (n=321), iMCD (n=105) or both (n=10). The transcriptomes of UCD and iMCD showed enrichment and upregulation of elements of the complement cascade. By immunohistochemistry, C4d deposits indicative of complement activation were found to be present in UCD and iMCD, mostly within abnormally regressed germinal centers, but also in association with plasma cell clusters, endothelial cells and stroma cell proliferations. Other enriched gene sets included collagen organization, S1P3 pathway and VEGFR pathway in UCD; and humoral response, oxidative phosphorylation and proteosome in iMCD. Analysis of cytokine transcripts showed upregulation of CXCL13 but not IL6 in UCD and iMCD. Among angiogenic mediators, the VEGFR1 ligand placental growth factor (PGF) was upregulated in both disease subtypes. We hereby report for the first time the whole lymph node transcriptomes of UCD and iMCD, underscoring findings that could aid in the discovery of targetable disease mediators.

摘要

卡斯尔曼病是一种多克隆淋巴组织增生性疾病,其特征为局灶性或多灶性淋巴结病,并具有特征性的组织形态学特征,此外还伴有不同程度的炎症症状。局灶性卡斯尔曼病(UCD)和特发性多中心卡斯尔曼病(iMCD)的分子机制和病因尚不清楚,且鉴定可靶向的疾病介质仍然是一个未满足的临床需求。我们对 UCD 和 iMCD 患者的淋巴结活检进行了全外显子组测序,并将转录组谱与良性对照淋巴结进行了比较。我们鉴定了 UCD(n=443)、iMCD(n=316)或两种疾病亚型(n=51)中显著上调的基因,以及 UCD(n=321)、iMCD(n=105)或两种疾病(n=10)中下调的基因。UCD 和 iMCD 的转录组显示补体级联的成分富集和上调。通过免疫组织化学染色,发现补体激活的 C4d 沉积存在于 UCD 和 iMCD 中,主要位于异常消退的生发中心内,但也存在于浆细胞簇、内皮细胞和基质细胞增生中。其他富集的基因集包括 UCD 中的胶原组织、S1P3 通路和 VEGFR 通路;以及 iMCD 中的体液反应、氧化磷酸化和蛋白酶体。细胞因子转录本分析显示 UCD 和 iMCD 中 CXCL13 上调,但 IL6 没有上调。在血管生成介质中,VEGFR1 配体胎盘生长因子(PGF)在两种疾病亚型中均上调。我们首次报告了 UCD 和 iMCD 的整个淋巴结转录组,强调了有助于发现可靶向疾病介质的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e87/9827154/336928021b5b/108207.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e87/9827154/4cb304e1d57d/108207.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e87/9827154/3361f4ad03c8/108207.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e87/9827154/336928021b5b/108207.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e87/9827154/4cb304e1d57d/108207.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e87/9827154/3361f4ad03c8/108207.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e87/9827154/336928021b5b/108207.fig3.jpg

相似文献

1
The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.局灶型和特发性多中心 Castleman 病的淋巴结转录组。
Haematologica. 2023 Jan 1;108(1):207-218. doi: 10.3324/haematol.2021.280370.
2
Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.特发性多中心和单中心 Castleman 病及滤泡树突状细胞肉瘤的下一代测序。
Blood Adv. 2018 Mar 13;2(5):481-491. doi: 10.1182/bloodadvances.2017009654.
3
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.病毒组捕获测序不能在局灶性和特发性多中心 Castleman 病中识别出活跃的病毒感染。
PLoS One. 2019 Jun 26;14(6):e0218660. doi: 10.1371/journal.pone.0218660. eCollection 2019.
4
[Not Available].[无可用内容]
Rev Med Interne. 2022 Dec;43(10S1):10S4-10S9. doi: 10.1016/S0248-8663(23)00019-X.
5
Novel somatic alterations in unicentric and idiopathic multicentric Castleman disease.局灶型和特发性多中心 Castleman 病中的新型体细胞改变。
Eur J Haematol. 2021 Dec;107(6):642-649. doi: 10.1111/ejh.13702. Epub 2021 Sep 21.
6
Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.HIV和HHV-8阴性的Castleman病的临床和病理特征
Blood. 2017 Mar 23;129(12):1658-1668. doi: 10.1182/blood-2016-11-748855. Epub 2017 Jan 18.
7
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms.Castleman 病中的 T 细胞亚群:包括单中心、多中心和 HHV8 相关临床形式的 28 例分析。
Int J Mol Sci. 2023 Apr 25;24(9):7813. doi: 10.3390/ijms24097813.
8
Peculiar hyper vascular manifestations in idiopathic multicentric castleman disease without tafro syndrome: a case report.无塔夫罗综合征的特发性多中心Castleman病中的特殊高血管表现:一例报告
Ann Hematol. 2024 Dec;103(12):5929-5934. doi: 10.1007/s00277-024-06040-z. Epub 2024 Oct 14.
9
From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.从 Castleman 病的组织病理学特征到特发性多中心 Castleman 病:一种排除潜在 iMCD 组织病理学模拟物的多参数方法。
J Clin Pathol. 2024 Apr 18;77(5):318-323. doi: 10.1136/jcp-2022-208696.
10
[Multicentric Castlemans disease. Symptoms, diagnostics and therapy].[多中心性Castleman病。症状、诊断与治疗]
Vnitr Lek. 2022 Winter;68(1):41-53.

引用本文的文献

1
The morphological spectrum of Castleman disease and related disorders: a report from the Lymphoma Workshop of the 22nd Meeting of the European Association of Hematopathology.Castleman病及相关疾病的形态学谱:欧洲血液病理学协会第22次会议淋巴瘤研讨会报告
Virchows Arch. 2025 Jul 12. doi: 10.1007/s00428-025-04171-w.
2
Spatial and single cell mapping of castleman disease reveals key stromal cell types and cytokine pathways.卡斯特曼病的空间和单细胞图谱揭示了关键的基质细胞类型和细胞因子途径。
Nat Commun. 2025 Jul 1;16(1):6009. doi: 10.1038/s41467-025-61214-1.
3
Herpesvirus-associated diseases: biomarkers and advancements in clinical research.

本文引用的文献

1
Transcriptome and unique cytokine microenvironment of Castleman disease.Castleman 病的转录组和独特的细胞因子微环境。
Mod Pathol. 2022 Apr;35(4):451-461. doi: 10.1038/s41379-021-00950-3. Epub 2021 Oct 22.
2
IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.IL-6 表达有助于区分肺部的 Castleman 病和 IgG4 相关疾病。
BMC Pulm Med. 2021 Jul 10;21(1):219. doi: 10.1186/s12890-021-01603-6.
3
Dynamic regulation of B cell complement signaling is integral to germinal center responses.
疱疹病毒相关疾病:生物标志物与临床研究进展
Virol J. 2025 Jun 2;22(1):177. doi: 10.1186/s12985-025-02795-7.
4
No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysis.通过病毒追踪分析,在单中心和特发性多中心Castleman病中未发现活动性病毒感染的证据。
Sci Rep. 2025 Jan 11;15(1):1676. doi: 10.1038/s41598-025-85193-x.
5
Interleukin-6 transcripts up-regulation in lymph nodes from unicentric and multicentric Castleman disease.单中心型和多中心型Castleman病患者淋巴结中白细胞介素-6转录本上调
EJHaem. 2024 Oct 23;5(6):1182-1189. doi: 10.1002/jha2.1034. eCollection 2024 Dec.
6
Spatial and Single Cell Mapping of Castleman Disease Reveals Key Stromal Cell Types and Cytokine Pathways.Castleman病的空间和单细胞图谱揭示关键基质细胞类型和细胞因子通路
bioRxiv. 2024 Sep 9:2024.09.09.609717. doi: 10.1101/2024.09.09.609717.
7
scRNA-seq reveals the landscape of immune repertoire of PBMNCs in iMCD.单细胞 RNA 测序揭示 iMCD 中 PBMNCs 免疫受体库的全景。
Oncogene. 2024 Sep;43(37):2795-2805. doi: 10.1038/s41388-024-03128-8. Epub 2024 Aug 15.
8
When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China.特发性多中心Castleman病遇上新型冠状病毒肺炎:一项来自中国的多中心回顾性研究
Ther Adv Hematol. 2024 Feb 14;15:20406207241229584. doi: 10.1177/20406207241229584. eCollection 2024.
9
Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.儿童 Castleman 病的临床特征和治疗结局:中国的一项回顾性队列研究。
Eur J Pediatr. 2023 Dec;182(12):5519-5530. doi: 10.1007/s00431-023-05235-2. Epub 2023 Oct 2.
10
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.特发性多中心Castleman病管理中未满足的临床需求:来自一个特设专家小组的基于共识的立场文件
Hemasphere. 2023 May 23;7(6):e891. doi: 10.1097/HS9.0000000000000891. eCollection 2023 Jun.
B 细胞补体信号的动态调控是生发中心反应的重要组成部分。
Nat Immunol. 2021 Jun;22(6):757-768. doi: 10.1038/s41590-021-00926-0. Epub 2021 May 24.
4
Increased mTOR activation in idiopathic multicentric Castleman disease.特发性多中心 Castleman 病中 mTOR 激活增加。
Blood. 2020 May 7;135(19):1673-1684. doi: 10.1182/blood.2019002792.
5
Overview of Castleman disease.卡斯特曼病概述。
Blood. 2020 Apr 16;135(16):1353-1364. doi: 10.1182/blood.2019000931.
6
Whole-exome sequencing identifies novel somatic alterations associated with outcomes in idiopathic multicentric Castleman disease.全外显子组测序鉴定出与特发性多中心Castleman病预后相关的新型体细胞改变。
Br J Haematol. 2020 Mar;188(5):e64-e67. doi: 10.1111/bjh.16330. Epub 2019 Dec 21.
7
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy.鞘氨醇 1-磷酸:病理与治疗中的脂质信号转导。
Science. 2019 Oct 18;366(6463). doi: 10.1126/science.aar5551.
8
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease.在 IL-6 阻断治疗抵抗性特发性多中心 Castleman 病中鉴定和靶向致病性 PI3K/AKT/mTOR 信号通路。
J Clin Invest. 2019 Aug 13;129(10):4451-4463. doi: 10.1172/JCI126091.
9
Role of osteopontin in dendritic cell shaping of immune responses.骨桥蛋白在树突状细胞免疫应答中的作用。
Cytokine Growth Factor Rev. 2019 Dec;50:19-28. doi: 10.1016/j.cytogfr.2019.05.004. Epub 2019 May 10.
10
POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.POEMS 综合征:2019 年关于诊断、风险分层和管理的更新。
Am J Hematol. 2019 Jul;94(7):812-827. doi: 10.1002/ajh.25495. Epub 2019 May 23.